脊髄神経刺激インプラントの世界市場：脊髄刺激装置、リードタイプ、用途、エンドユーザー別-2025-2030年予測

脊髄神経刺激インプラント市場の2023年の市場規模は41億4,000万米ドルで、2024年には47億7,000万米ドルに達すると予測され、CAGR 15.74％で成長し、2030年には115億3,000万米ドルに達すると予測されています。

脊髄神経刺激インプラント市場の中心は、脊髄に電気インパルスを送ることで脳への疼痛信号を遮断し、慢性疼痛を管理するために設計された機器です。これらのインプラントの必要性は、主に慢性腰痛、腰痛手術失敗症候群、複合性局所疼痛症候群のような、効果的な長期疼痛管理ソリューションを必要とする疾患の有病率の上昇に起因します。これらの器具は、薬物療法などの従来の疼痛緩和方法では不十分であることが証明された場合に適用されます。最終用途の範囲は多岐にわたり、病院や専門クリニックから、低侵襲治療の選択肢を求める患者層の増加に対応する外来外科センターまで広がっています。

市場の洞察により、神経刺激装置の技術的進歩、前述の疾患の罹患率の増加、非薬物的介入に対する患者や臨床医の嗜好の高まりなど、成長に影響を与えるいくつかの主要要因が明らかになった。潜在的なビジネスチャンスは、新興市場におけるこれらのインプラントの普及、高度な疼痛管理療法に対する認識と受容の高まり、機器の小型化と電池寿命の進歩にあります。企業は、バイオエレクトロニクスの調査強化、デバイス最適化のための人工知能統合、患者のカスタマイズ機能の強化によって、こうした動向を活用することができます。

しかし、脊髄インプラントに関連する高コスト、償還の問題、迅速な機器承認を妨げる規制上のハードルなど、市場はいくつかの制約に直面しています。さらに、移植の実施には高度な技術を有する専門家が必要であり、術後に合併症を引き起こす可能性があることも、市場の課題となっています。

技術革新と研究のための最良の分野としては、より広い市場へのアクセスを可能にする費用対効果の高いモデルの開発、ワイヤレス神経刺激技術の改良、治療を調整するためのビッグデータ分析の活用などが挙げられます。市場の性質はダイナミックであり、技術の進化と患者中心のソリューションが重視されます。この分野での成長を目指す企業は、技術格差を埋め、ヘルスケア提供システムを強化するための戦略的協力やパートナーシップに注力すべきです。

市場力学：急速に進化する脊髄神経刺激インプラント市場の主要市場インサイトを公開

脊髄神経刺激インプラント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 故障性背部症候群、慢性疼痛、複合性局所疼痛症候群（CRPS）に苦しむ患者の有病率の増加
  • 神経疾患の研究開発投資の増加
  • 低侵襲神経外科手術に対する需要の高まり
• 市場抑制要因
  • 脊髄刺激装置に関連する有害リスク
• 市場機会
  • 人々の意識の高まりと償還政策の改善
  • 脊髄神経刺激インプラントの進歩
• 市場の課題
  • 代替療法の利用可能性

ポーターの5つの力：脊髄神経刺激インプラント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脊髄神経刺激インプラント市場における外部からの影響の把握

外部マクロ環境要因は、脊髄神経刺激インプラント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脊髄神経刺激インプラント市場における競合情勢の把握

脊髄神経刺激インプラント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脊髄神経刺激インプラント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脊髄神経刺激インプラント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脊髄神経刺激インプラント市場における成功への道筋を描く

脊髄神経刺激インプラント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腰痛症候群、慢性疼痛、複合性局所疼痛症候群（CRPS）に苦しむ患者の有病率が増加
    • 神経疾患の研究開発への投資の増加
    • 低侵襲脳神経外科手術の需要増加
  • 抑制要因
    • 脊髄刺激装置に関連する有害リスク
  • 機会
    • 国民の意識向上と償還政策の改善
    • 脊髄神経刺激インプラントの進歩
  • 課題
    • 代替療法の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脊髄神経刺激インプラント市場脊髄刺激装置別

• 従来のシステム
• 無線周波数システム
• 充電式システム

第7章 脊髄神経刺激インプラント市場リードタイプ別

• 円筒形リード
• パドルリード

第8章 脊髄神経刺激インプラント市場：用途別

• 変性椎間板疾患
• 背部手術失敗症候群
• 坐骨神経痛

第9章 脊髄神経刺激インプラント市場：エンドユーザー別

• 外来手術センター
• 病院
• 理学療法センター

第10章 南北アメリカの脊髄神経刺激インプラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の脊髄神経刺激インプラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの脊髄神経刺激インプラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Axonics Modulation Technologies, Inc.
• Beijing PINS Medical Co., Ltd.
• Boston Scientific Corporation
• Cirtec Medical Corp.
• Helius Medical Technologies, Inc.
• iSpine Clinics
• Medtronic PLC
• Nalu Medical, Inc.
• NeuroMetrix, Inc.
• NeuroPace, Inc.
• Nevro Corp.
• Saluda Medical Pty Ltd
• Stimwave LLC
• Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET RESEARCH PROCESS
• FIGURE 2. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET DYNAMICS
• TABLE 7. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CONVENTIONAL SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY RADIOFREQUENCY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY RECHARGEABLE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CYLINDRICAL LEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PADDLE LEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY DEGENERATIVE DISK DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SCIATICA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PHYSIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 36. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 58. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 62. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 131. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 147. POLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 151. QATAR SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATOR, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

The Spinal Cord Neurostimulation Implant Market was valued at USD 4.14 billion in 2023, expected to reach USD 4.77 billion in 2024, and is projected to grow at a CAGR of 15.74%, to USD 11.53 billion by 2030.

The Spinal Cord Neurostimulation Implant market is centered on devices designed to manage chronic pain by delivering electrical impulses to the spinal cord, thereby interrupting pain signals to the brain. The necessity for these implants is primarily due to the rising prevalence of conditions like chronic back pain, failed back surgery syndrome, and complex regional pain syndrome, which demand effective long-term pain management solutions. These devices are applied in scenarios where conventional pain relief methods, such as medications, have proven inadequate. The end-use scope is varied, spanning from hospitals and specialist clinics to outpatient surgical centers that cater to a growing demographic of patients seeking minimally invasive treatment options.

Market insights reveal several key factors influencing growth, including technological advancements in neurostimulation devices, increasing incidence of the aforementioned conditions, and rising patient and clinician preference for non-pharmaceutical interventions. The potential opportunities reside in the penetration of these implants in emerging markets, increasing awareness and acceptance of advanced pain management therapies, and advancements in device miniaturization and battery life. Companies can capitalize on these trends by intensifying research in bioelectronics, artificial intelligence integration for device optimization, and enhancing patient customization features.

However, the market faces several limitations such as high costs associated with spinal cord implants, reimbursement issues, and regulatory hurdles that could impede swift device approvals. Additionally, the market is challenged by the need for highly skilled professionals to perform implantations and potential complications post-surgery.

The best areas for innovation and research include developing cost-effective models for wider market accessibility, refining wireless neurostimulation technologies, and harnessing big data analytics to tailor treatment. The nature of the market is dynamic, with a strong emphasis on technological evolution and patient-centric solutions. Companies aiming for growth in this space should focus on strategic collaborations and partnerships to bridge technology gaps and enhance healthcare delivery systems.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spinal Cord Neurostimulation Implant Market

The Spinal Cord Neurostimulation Implant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence rate of patients suffering from the failed back syndrome, chronic pain, and complex regional pain syndrome (CRPS)
  • Increase in investments in R&D for neurological disorders
  • Rising demand for minimally invasive neurosurgeries
• Market Restraints
  • Adverse risks associated with spinal cord stimulation devices
• Market Opportunities
  • Increasing awareness among the people and improvement in the reimbursement policies
  • Advancements in spinal cord neurostimulation implant
• Market Challenges
  • Availability of substitute therapies

Porter's Five Forces: A Strategic Tool for Navigating the Spinal Cord Neurostimulation Implant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spinal Cord Neurostimulation Implant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spinal Cord Neurostimulation Implant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spinal Cord Neurostimulation Implant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spinal Cord Neurostimulation Implant Market

A detailed market share analysis in the Spinal Cord Neurostimulation Implant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spinal Cord Neurostimulation Implant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spinal Cord Neurostimulation Implant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spinal Cord Neurostimulation Implant Market

A strategic analysis of the Spinal Cord Neurostimulation Implant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spinal Cord Neurostimulation Implant Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Axonics Modulation Technologies, Inc., Beijing PINS Medical Co., Ltd., Boston Scientific Corporation, Cirtec Medical Corp., Helius Medical Technologies, Inc., iSpine Clinics, Medtronic PLC, Nalu Medical, Inc., NeuroMetrix, Inc., NeuroPace, Inc., Nevro Corp., Saluda Medical Pty Ltd, Stimwave LLC, and Synapse Biomedical Inc..

Market Segmentation & Coverage

This research report categorizes the Spinal Cord Neurostimulation Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Spinal Cord Stimulator, market is studied across Conventional System, Radiofrequency System, and Rechargeable System.
• Based on Lead Type, market is studied across Cylindrical Leads and Paddle Leads.
• Based on Application, market is studied across Degenerative Disk Disease, Failed Back Surgery Syndrome, and Sciatica.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Physiotherapy Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence rate of patients suffering from the failed back syndrome, chronic pain, and complex regional pain syndrome (CRPS)
    • 5.1.1.2. Increase in investments in R&D for neurological disorders
    • 5.1.1.3. Rising demand for minimally invasive neurosurgeries
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse risks associated with spinal cord stimulation devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing awareness among the people and improvement in the reimbursement policies
    • 5.1.3.2. Advancements in spinal cord neurostimulation implant
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of substitute therapies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spinal Cord Neurostimulation Implant Market, by Spinal Cord Stimulator

• 6.1. Introduction
• 6.2. Conventional System
• 6.3. Radiofrequency System
• 6.4. Rechargeable System

7. Spinal Cord Neurostimulation Implant Market, by Lead Type

• 7.1. Introduction
• 7.2. Cylindrical Leads
• 7.3. Paddle Leads

8. Spinal Cord Neurostimulation Implant Market, by Application

• 8.1. Introduction
• 8.2. Degenerative Disk Disease
• 8.3. Failed Back Surgery Syndrome
• 8.4. Sciatica

9. Spinal Cord Neurostimulation Implant Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals
• 9.4. Physiotherapy Centers

10. Americas Spinal Cord Neurostimulation Implant Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Spinal Cord Neurostimulation Implant Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Spinal Cord Neurostimulation Implant Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Axonics Modulation Technologies, Inc.
• 3. Beijing PINS Medical Co., Ltd.
• 4. Boston Scientific Corporation
• 5. Cirtec Medical Corp.
• 6. Helius Medical Technologies, Inc.
• 7. iSpine Clinics
• 8. Medtronic PLC
• 9. Nalu Medical, Inc.
• 10. NeuroMetrix, Inc.
• 11. NeuroPace, Inc.
• 12. Nevro Corp.
• 13. Saluda Medical Pty Ltd
• 14. Stimwave LLC
• 15. Synapse Biomedical Inc.